[Hepatitis B virus resistance to entecavir]. 2012

Carmen Hidalgo-Tenorio, and Mar Rivero, and Marta Alvarez, and Federico García

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006147 Guanine
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D019694 Hepatitis B, Chronic INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Chronic Hepatitis B,Chronic Hepatitis B Virus Infection,Hepatitis B Virus Infection, Chronic
D024882 Drug Resistance, Viral The ability of viruses to resist or to become tolerant to chemotherapeutic agents or antiviral agents. This resistance is acquired through gene mutation. Antiviral Drug Resistance,Antiviral Drug Resistances,Drug Resistances, Viral

Related Publications

Carmen Hidalgo-Tenorio, and Mar Rivero, and Marta Alvarez, and Federico García
April 2017, Hepatology communications,
Carmen Hidalgo-Tenorio, and Mar Rivero, and Marta Alvarez, and Federico García
December 2006, Hepatology (Baltimore, Md.),
Carmen Hidalgo-Tenorio, and Mar Rivero, and Marta Alvarez, and Federico García
February 2010, PloS one,
Carmen Hidalgo-Tenorio, and Mar Rivero, and Marta Alvarez, and Federico García
June 2010, The Korean journal of hepatology,
Carmen Hidalgo-Tenorio, and Mar Rivero, and Marta Alvarez, and Federico García
February 2009, Antiviral research,
Carmen Hidalgo-Tenorio, and Mar Rivero, and Marta Alvarez, and Federico García
July 2009, Mikrobiyoloji bulteni,
Carmen Hidalgo-Tenorio, and Mar Rivero, and Marta Alvarez, and Federico García
May 2008, Hepatology (Baltimore, Md.),
Carmen Hidalgo-Tenorio, and Mar Rivero, and Marta Alvarez, and Federico García
November 2006, Medizinische Monatsschrift fur Pharmazeuten,
Carmen Hidalgo-Tenorio, and Mar Rivero, and Marta Alvarez, and Federico García
April 2007, Journal of virology,
Carmen Hidalgo-Tenorio, and Mar Rivero, and Marta Alvarez, and Federico García
February 2017, Journal of viral hepatitis,
Copied contents to your clipboard!